CSF, Encephalopathy, Autoimmune/Paraneoplastic Evaluation Build info

Synonyms

  • ENCEPHALOPATHY EVAL,CSF
  • ENC1
  • ENCEPHALOPATHY EVAL,CSF
  • LAB11489

Short Name

ENCEPHALOPATHY EVAL,CSF

Procedure Master Number

LAB11489

Procedure ID

115303

Clinical Info

Evaluating new onset encephalopathy (noninfectious or metabolic) comprising confusional states, psychosis, delirium, memory loss, hallucinations, movement disorders, sensory or motor complaints, seizures, dyssomnias, ataxias, nausea, vomiting, inappropriate antidiuresis, coma, dysautonomias, or hypoventilation in spinal fluid specimens

Specimen Type

CSF

Container

Sterile

Collection Instructions

Container/Tube: Sterile Vial
Specimen: 4 mL CSF (2 mL min)
This test is intended to be ordered for adult patients. If this test is ordered for a patient younger than 18 years of age,
 it will be canceled and automatically reordered by the laboratory as PCDEC / Pediatric Autoimmune
  Encephalopathy/CNS Disorder Evaluation, Spinal Fluid.

Transport Instructions

72 Hours Room Temperature

Specimen Stability

3 Days Room Temperature
28 Days Refrigerated
28 Days Frozen

Methodology

Indirect Immunofluorescence Assay (IFA)
Cell-Binding Assay (CBA)
Western Blot (WB)
Immunoblot (IB)
Radioimmunoassay (RIA)

Days Performed

TAT: 9 - 13 Days

Performing Laboratory

Mayo Medical Laboratories

CPT

86255 x 23
86341
LOINC Code: 94708-5

PDM

1759170

Results
Component Name Base Name Common Name External Name
AMPA-R AB CBA, CSF AMPARABCBA AMPA R AB CBA, CSF Ampa-R Ab Cba, Csf
AMPHIPHYSIN AB, CSF AMPHIPHYABC AMPHIPHYSIN AB, CSF Amphiphysin Ab, Csf
ANTI-GLIAL NUCLEAR AB, TYPE 1 GLIALNUCAB1 ANTI GLIAL NUCLEAR AB, TYPE 1 Anti-Glial Nuclear Ab, Type 1
ANTI-NEURONAL NUCLEAR AB, TYPE 1 ANNAB ANTI NEURONAL NUCLEAR AB, TYPE 1 Anti-Neuronal Nuclear Ab, Type 1
ANTI-NEURONAL NUCLEAR AB, TYPE 2 ANNAB ANTI NEURONAL NUCLEAR AB, TYPE 2 Anti-Neuronal Nuclear Ab, Type 2
ANTI-NEURONAL NUCLEAR AB, TYPE 3 ANNAB ANTI NEURONAL NUCLEAR AB, TYPE 3 Anti-Neuronal Nuclear Ab, Type 3
CASPR2-IGG CBA, CSF CASPR2 CASPR2 IGG CBA, CSF Caspr2-Igg Cba, Csf
CRMP-5-IGG, CSF CRMP5IGGCSF CRMP 5 IGG, CSF Crmp-5-Igg, Csf
DPPX AB IFA, CSF DPPXABIFACSF DPPX AB IFA, CSF Dppx Ab Ifa, Csf
ENCEPHALOPATHY, INTERPRETATION, CSF ENCEPHINTCSF ENCEPHALOPATHY, INTERPRETATION, CSF Encephalopathy, Interpretation, Csf
GABA-B-R AB CBA, CSF GABABRCSF GABA B R AB CBA, CSF Gaba-B-R Ab Cba, Csf
GAD65 AB ASSAY, CSF GAD65 GAD65 AB ASSAY, CSF Gad65 Ab Assay, Csf
GFAP IFA, CSF GFAP GFAP IFA, CSF Gfap Ifa, Csf
IFA NOTES IFANOTES IFA NOTES Ifa Notes
IGLON5 IFA, CSF IGLON5IFA IGLON5 IFA, CSF Iglon5 Ifa, Csf
LGI1-IGG CBA, CSF LG1IGGCSF LGI1 IGG CBA, CSF Lgi1-Igg Cba, Csf
MGLUR1 AB IFA, CSF MGLUR1 MGLUR1 AB IFA, CSF Mglur1 Ab Ifa, Csf
NIF IFA, CSF NIFIFA NIF IFA, CSF Nif Ifa, Csf
NMDA-R AB CBA, CSF NMDARABCBA NMDA R AB CBA, CSF Nmda-R Ab Cba, Csf
PURKINJE CELL CYTOPLASMIC AB TYPE 1 PURCYTO1 PURKINJE CELL CYTOPLASMIC AB TYPE 1 Purkinje Cell Cytoplasmic Ab Type 1
PURKINJE CELL CYTOPLASMIC AB TYPE 2 PURCYTO2 PURKINJE CELL CYTOPLASMIC AB TYPE 2 Purkinje Cell Cytoplasmic Ab Type 2
PURKINJE CELL CYTOPLASMIC AB TYPE TR PURCYTOTR PURKINJE CELL CYTOPLASMIC AB TYPE TR Purkinje Cell Cytoplasmic Ab Type Tr
REFLEX ADDED REFADD REFLEX ADDED Reflex Added